mifepristone has been researched along with Colonic Neoplasms in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jia, L; Liu, J; Wan, L; Xu, H; Xu, J; Zheng, N | 1 |
Check, D; Check, JH; Dix, E; Sansoucie, L | 1 |
Chen, J; Fang, GE; Liu, XS; Qian, QJ; Su, CQ; Wang, F; Xue, XC | 1 |
Check, D; Check, JH; Cohen, R; Dix, E; Wilson, C | 1 |
Daly, JM; Evoy, D; Fujita, J; Mackrell, P; McCarter, MD; Naama, HA; Rivadeneira, DE | 1 |
5 other study(ies) available for mifepristone and Colonic Neoplasms
Article | Year |
---|---|
HAMPT, A Novel Quadruple Drug Combination Designed for Cancer Metastatic Chemoprevention: From Hypothesis to Proof-of-concept.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Aspirin; Cell Cycle; Cell Proliferation; Colonic Neoplasms; Doxycycline; Drug Therapy, Combination; Female; Hormone Antagonists; Humans; Lysine; Mice; Mice, Inbred BALB C; Mice, Nude; Mifepristone; Proof of Concept Study; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2019 |
Mifepristone may halt progression of extensively metastatic human adenocarcinoma of the colon - case report.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Colonic Neoplasms; Disease Progression; Female; Humans; Male; Middle Aged; Mifepristone; Neoplasm Metastasis; Quality of Life | 2009 |
[Construction of a RU486 inducible recombinant adenoviral vector carrying murine interleukin-12 gene and experimental treatment of colonic carcinoma].
Topics: Adenoviridae; Animals; Cell Line, Tumor; Colonic Neoplasms; Female; Gene Transfer Techniques; Genetic Therapy; Genetic Vectors; Interleukin-12; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Mifepristone; Neoplasms, Experimental; Recombinant Fusion Proteins; Transduction, Genetic; Transfection | 2009 |
Efficacy of the progesterone receptor antagonist mifepristone for palliative therapy of patients with a variety of advanced cancer types.
Topics: Adult; Aged; Carcinoma, Transitional Cell; Colonic Neoplasms; Female; Histiocytoma, Malignant Fibrous; Hormone Antagonists; Humans; Kidney Neoplasms; Leiomyosarcoma; Male; Middle Aged; Mifepristone; Neoplasms; Palliative Care; Pancreatic Neoplasms; Receptors, Progesterone; Survival Rate; Thymus Neoplasms; Treatment Outcome; Young Adult | 2010 |
Glucocorticoid blockade does not abrogate tumor-induced cachexia.
Topics: Adenocarcinoma; Animals; Body Composition; Body Weight; Cachexia; Colonic Neoplasms; Female; Glucocorticoids; Hormone Antagonists; Interleukin-6; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Mifepristone; Neoplasm Transplantation; Regression Analysis; Tumor Cells, Cultured | 1999 |